Marco Valgimigli, MD, PhD, FESC

One-Year Clinical Outcome after Coronary Stenting of Very Small Vessels Using 2.25 mm Sirolimus- and Paclitaxel-Eluting Stents:

08/01/2008

Pim J. de Feyter , MD, PhD;

Ron T. van Domburg , PhD;

Hector M. Garcia-Garcia , MD, PhD;

Andrew T.L. Ong , MD, MBBS, PhD;

Carlos A.G. van Mieghem , MD;

Keiichi Tsuchida , MD;

Gaston A. Alfredo Rodriguez-Granillo , MD;

Jiro Aoki , MD;

Marco Valgimigli , MD, PhD, FESC;

Patrick W. Serruys , MD, PhD;

Eugene P. McFadden , MB, MD;

Georgios Sianos , MD, PhD;

Willem J. van der Giessen , MD, PhD;

Coronary stenting has significantly improved the angiographic and clinical outcomes in vessels with a reference diameter (RD) > 3 mm.1–5 However, several randomized trials have shown conflicting results when comparing coronary stenting...

Coronary stenting has...

08/01/2008

Journal of Invasive Cardiology

Original Contribution

In-Hospital Management and Outcome of Patients on Warfarin Undergoing Coronary Stent Implantation: Results of the Multicenter, Prospective WARfarin and Coronary STENTing (WAR-STENT) Registry

04/01/2013

Giacomo Piccalo , MD;

Elisabetta Varani , MD;

Massimo Margheri , MD;

Leonardo Bolognese , MD;

Giuseppe Di Pasquale , MD;

Alessandro Sciahbasi , MD, PhD;

Marcello Galvani , MD;

Lucio Gonzini , BSc;

Andrea Rubboli , MD;

Aldo Pietro Maggioni , MD;

Francesco Saia , MD, PhD;

Cataldo Palmieri , MD;

Luigi Andrea Moroni , MD;

Paolo Calabro , MD;

Antonio Maria Leone , MD, PhD;

Nicoletta Franco , MD;

Carlo Briguori , MD, PhD;

Marco Valgimigli , MD, PhD, FESC;

Michela Santi , MD;

Paola Pasqualini , MD;

Alessandro Capecchi , MD;

To determine the adherence to the current recommendations, and the incidence of adverse events, we carried out the prospective, multi-center, observational WARfarin and coronary STENTing (WAR-STENT) registry. All consecutive patients on...

To determine the adherence to...

04/01/2013

Journal of Invasive Cardiology

Original Contribution

Outcome of Patients on Oral Anticoagulation Undergoing Coronary Artery Stenting: Data From Discharge to 12 Months in the Warfarin and Coronary Stenting (WAR-STENT) Registry

10/27/2014

Marcello Galvani , MD;

Aldo Pietro Maggioni , MD;

Carlo Briguori , MD, PhD;

Maria Letizia Bacchi-Reggiani , MSc;

Luigi Steffanon , MD;

Andrea Rizzi , MD;

Ferdinando Imperadore , MD;

Giuseppe Carosio , MD;

Giuseppe Steffenino , MD;

Luigi La Vecchia , MD, FESC;

Giueseppe Massimo Sangiorgi , MD, PhD;

Andrea Rubboli , MD;

Leonardo Bolognese , MD;

Francesco Saia , MD, PhD;

Alessandro Sciahbasi , MD, PhD;

Cataldo Palmieri , MD;

Paolo Calabro , MD;

Marco Valgimigli , MD, PhD, FESC;

Giuseppe Di Pasquale , MD;

This study obtains further, and more focused, information on the efficacy and safety of three antithrombotic regimens prescribed to patients on oral anticoagulation undergoing percutaneous coronary intervention with stent implantation by...

This study obtains further, and...

10/27/2014

Journal of Invasive Cardiology

Comparing Antiplatelet Therapy in STEMI: The FABOLUS-FASTER Trial

09/07/2020

Marco Valgimigli , MD, PhD, FESC;

Ralph J. Riello III, PharmD, BCPS;

The big surprise from the study is that the non-inferiority of cangrelor versus tirofiban was not met. Tirofiban was clearly superior to cangrelor. Among the 4 regimens, the mean level of platelet inhibition that can be achieved at 30 minutes...

The big surprise from the study...

09/07/2020

Cath Lab Digest

Original Contribution

Ultra-Short Term Evaluation of Coronary Vessel Wall Changes in Reference Segments Adjacent to Culprit Lesions in ST-Segment Elevation Myocardial Infarction

12/01/2021

Giuseppe Andò , MD;

Stefano Rigattieri , MD, PhD;

Stefano Garducci , MD;

Ferdinando Varbella , MD;

Alexios Karagiannis , MD;

Cataldo Palmieri , MD;

Roberto Diletti , MD, PhD;

Jouke Dijkstra , PhD;

Paolo Calabro , MD;

Marianna Adamo , MD;

Andrea Picchi , MD;

Marco Valgimigli , MD, PhD, FESC;

Gennaro Sardella , MD, PhD;

Ugo Limbruno , MD, PhD;

Kazuhiro Dan , MD, PhD;

Carlo Briguori , MD, PhD;

Hector M. Garcia-Garcia , MD, PhD;

Omar Yacob , MD;

Kayode O. Kuku , MD;

Miguel A. Diaz-Torres , MD;

Enrico Frigoli , MD;

Giacomo Boccuzzi , MD;

Marco Zimarino , MD;

Marco Contarini , MD;

Filippo Russo , MD;

Kazuhiro Dan, MD, PhD and colleagues compared separately the fate of residual dissection and luminal area/dimension by OCT in the target vessel between pPCI and staged PCI, including 1-year clinical outcomes.

Kazuhiro Dan, MD, PhD and...

12/01/2021

Journal of Invasive Cardiology